Why the Little Green Pharma (ASX:LGP) share price has lost 20% since July

The medicinal cannabis producer's shares have fallen heavily in recent times…

| More on:
Hipster man puts head in hand as he talks on phone in front while sitting at a desk.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Little Green Pharma Ltd (ASX: LGP) share price has had a tough run over the past few months. This comes despite the medicinal cannabis producer releasing some positive announcements to the market of late.

At Friday's closing bell, Little Green Pharma shares finished the day down 2.04% to 72 cents apiece. They are now down 22.5% since the start of July

What has Little Green Pharma recently announced?

In late August, Little Green Pharma released its preliminary report for the 2021 financial year, highlighting mixed results.

The company generated more than $7 million in revenue, up 218% over the prior corresponding period. The robust performance came from the sale of medicinal oil and flower products.

On Little Green Pharma's bottom line, profit after tax came to $24.6 million, an improvement from the $9.3 million loss in FY20. While this appears a sound performance, the $25 million gain on the purchase of the Denmark facility bumped up the end result.

In addition to the result, Little Green Pharma was granted a Schedule 9 licence to supply psilocybin by the Western Australian government. The licence is a key element of the company's entry into the international field of psychedelic drugs to treat mental illness.

Furthermore, Little Green Pharma successfully imported its first shipment of its THC 16 cannabis flower medicine from its Danish facility into Australia. The Little Green Pharma share price jumped on this news.

Regardless of the positive progress, Little Green Pharma shares have tanked from the beginning of July. Its peers too, Creso Pharma Ltd (ASX: CPH) and Althea Group Holdings Ltd (ASX: AGH) have not been immune. They have fallen 12.5% and 27%, respectively.

A possible catalyst for the fall could be weak investor sentiment as the cannabis sector has been slow to take off. In 2018, there was massive hype in cannabis products, but this has since waned.

About the Little Green Pharma share price

Over the past 12 months, Little Green Pharma shares gradually moved upwards to advance around 150%. The strong accent came off the back of late 2020 where the cannabis sector took off following optimistic investor sentiment.

However, in 2021, the company's share price moved relatively sideways, registering gains of approximately 30%.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »